In this issue:
Pembrolizumab vs ipilimumab in advanced melanoma: Post-hoc 5-year results
Epacadostat + pembrolizumab vs placebo + pembrolizumab in patients with unresectable or metastatic melanoma
CNN outperformed pathologists in the classification of histopathological melanoma images
Effect of concomitant ARAs and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib
Prognostic and predictive value of AJCC-8 staging in the EORTC1325/KEYNOTE-054 trial
Efficacy of PD-1 immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
Survival outcomes in early stage desmoplastic melanoma +/- adjuvant radiation
Radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies
Melanoma and other skin cancer risk in airline pilots and cabin crew
Please login below to download this issue (PDF)